source
- FDA rejects ITM Isotope's radiopharmaceutical therapy over manufacturing problems, halting potential competitor to NovartisThe U.S. Food and Drug Administration has refused to approve a radiopharmaceutical therapy developed by ITM Isotope Technologies Munich SE, citing manufacturing deficiencies. The therapy was desig…
- Skylark Bio launches first-in-human gene therapy trial targeting deafnessSkylark Bio, which has operated in stealth, announced that it has dosed the first patient in a gene-therapy trial aimed at treating hearing loss. The study marks the company's entry into the emergi…